Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,391 | 12,205 | 14,231 | 20,945 | 13,528 |
| Marketable Securities | 67,337 | 78,211 | 92,673 | 107,458 | 132,762 |
| Receivables | N/A | 3,000 | N/A | N/A | N/A |
| TOTAL | $83,073 | $99,956 | $111,871 | $132,440 | $148,868 |
| Non-Current Assets | |||||
| PPE Net | 8,460 | 8,924 | 9,403 | 9,899 | 10,396 |
| Intangibles | 2,434 | 2,488 | 2,544 | 2,600 | 23,619 |
| Other Non-Current Assets | 11,637 | 11,847 | 12,049 | 12,242 | 12,428 |
| TOTAL | $22,531 | $23,259 | $23,996 | $24,741 | $46,443 |
| Total Assets | $105,604 | $123,215 | $135,867 | $157,181 | $195,311 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,756 | 9,412 | 2,846 | 4,859 | 4,870 |
| Accrued Expenses | 7,996 | 6,698 | 10,076 | 11,371 | 14,057 |
| TOTAL | $19,382 | $17,678 | $14,430 | $17,680 | $20,320 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,443 | 17,894 | 18,334 | 18,750 | 19,147 |
| TOTAL | $17,443 | $17,894 | $18,334 | $18,750 | $21,311 |
| Total Liabilities | $36,825 | $35,572 | $32,764 | $36,430 | $41,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,264 | 62,018 | 61,948 | 61,590 | 59,466 |
| Common Shares | 62 | 62 | 62 | 60 | 59 |
| Retained earnings | -425,071 | -403,068 | -384,714 | -363,556 | -327,985 |
| Other shareholders' equity | 69 | -5 | 49 | 170 | 351 |
| TOTAL | $68,779 | $87,643 | $103,103 | $120,751 | $153,680 |
| Total Liabilities And Equity | $105,604 | $123,215 | $135,867 | $157,181 | $195,311 |